Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today ...

Dreams are often born through the experiences that challenge and shape us, evolving from moments of personal impact into a ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

Regular Abstracts Accepted as Poster Presentations Presentation Title: Soluble Immune Biomarker Profiling of Chronic Hepatitis B Subjects Treated with Imdusiran in Combination with Pegylated ...

The Ebola virus market is focused on developing vaccines and treatments to address outbreaks of this deadly virus. There are currently 18+ key companies involved, including major players like Auro ...

Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools. According to ...

A recent study suggests that a carbohydrate-rich breakfast for men and a fat-rich breakfast for women may be best for ...

Alzheimer’s Disease May Damage the Brain in Two Phases - NIH Study Uncovers Which Cell Types May Be Harmed First ...

The province cut the ribbon Thursday on Calgary's new cancer care centre, one that Premier Danielle Smith and Health Minister ...

Innate immunity represents an important arm of immune response, vital to sensing damages, pathogenic or non-pathogenic, and to repair the injury tissue. It comprehends several elements including ...

New Initiative to Expand Access and Increase Diversity in Cancer Clinical Trials DURHAM, NC, UNITED STATES, October 17, 2024 /EI ...

However, the market is expected to grow significantly between 2022 and 2032, with a projected growth rate of 7%, which is ...